Rise in Valvular Heart Disease & Adoption of TAVR as the Standard Surgical Intervention in Disease Management to Drive the Prosthetic Heart Valves Market
Rise in valvular heart disease and the widespread adoption of transcatheter aortic valve replacement (TAVR) as the standard of care against the backdrop of growing preference for minimally invasive heart valve replacement procedures are poised to drive the global Prosthetic Heart Valves market to reach US$9.7 billion by 2024 . Prosthetic heart valves are used for replacing malfunctioning, deformed or diseased native heart valves in order to restore normal functioning of the heart. Aging population, changing lifestyles and growing prevalence of other diseases such as hypertension and cholesterol are driving the prevalence of heart valve disorders. This in turn is fueling the volume of heart valve replacement procedures performed each year, worldwide. Mechanical heart valve represents the conventional form of prosthetic heart valve, which continues to be used despite their decline in popularity in developed countries. Indicated mainly for use in younger patient population due to th...